These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2106690)

  • 21. von Willebrand disease: from the bedside to therapy.
    Aledort LM
    Thromb Haemost; 1997 Jul; 78(1):562-5. PubMed ID: 9198216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An inherited hemostatic disorder as the cause of menorrhagia].
    Leebeek FW; Lotgering FK
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):545-8. PubMed ID: 11938574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thromboembolism of the pulmonary artery in Willebrand's disease].
    Galstian GM; Vasil'ev SA; Galuziak VS; Likhacheva EA; Pliushch OP; Rudakova VE; Riazanova IB; Sakhibov IaD; Togonidze DK; Khorobrykh LS
    Ter Arkh; 2005; 77(12):33-9. PubMed ID: 16514817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 25. Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graft.
    Gerling V; Lahpor JR; Buhre W
    Anaesthesia; 2007 Apr; 62(4):405-8. PubMed ID: 17381580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing excessive bleeding in patients with von Willebrand disease.
    Gill JC
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):207-9. PubMed ID: 16728929
    [No Abstract]   [Full Text] [Related]  

  • 30. Acquired von Willebrand's disease following bone marrow transplantation.
    Lazarchick J; Green C
    Ann Clin Lab Sci; 1994; 24(3):211-5. PubMed ID: 8048792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plasma-derived von Willebrand factor/factor VIII concentrate (Wilate).
    Med Lett Drugs Ther; 2010 Jun; 52(1340):46-7. PubMed ID: 20539265
    [No Abstract]   [Full Text] [Related]  

  • 32. Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.
    Over J; Sixma JJ; Bouma BN; Bolhuis PA; Vlooswijk RA; Beeser-Visser NH
    J Lab Clin Med; 1981 Mar; 97(3):332-44. PubMed ID: 6780640
    [No Abstract]   [Full Text] [Related]  

  • 33. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Von Willebrand's disease complicating second-trimester abortion.
    Sorosky J; Klatsky A; Nobert GF; Burchell RC
    Obstet Gynecol; 1980 Feb; 55(2):253-4. PubMed ID: 6965426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Variant type von Willebrand disease with defective binding to factor VIII].
    Shima M
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534
    [No Abstract]   [Full Text] [Related]  

  • 36. Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
    Federici AB; Mannucci PM; Marco P
    Haemophilia; 2008 Jan; 14(1):133-9. PubMed ID: 17941830
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of severe menorrhagia at menarche with recombinant factor VIIa in an adolescent girl with type III von Willebrand's disease.
    Gokcebay DG; Culha V; Yarali N; Ozbek NY
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):469-471. PubMed ID: 29750671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.
    Rahmani R; Rozen P; Papo J; Iellin A; Seligsohn U
    Isr J Med Sci; 1990 Sep; 26(9):504-9. PubMed ID: 2121664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis in von Willebrand disease.
    Franchini M; Targher G; Lippi G
    Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of von Willebrand's disease].
    Rafanelli D; Vannucchi AM; Morfini M
    G Clin Med; 1988 Jan; 69(1):63-6. PubMed ID: 3133271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.